| Website | medrobotics.com |
| Category | BioTech |
| Employees |
| TOTAL | $53.3M |
| FUNDING TOTAL | $53.3M |
| Series C, 11/11 | $11.7M |
| Venture Round, 8/12 | $8M |
| Series D, 12/12 | $33.6M |
| DEBT TOTAL | $10M |
| Debt, 3/13 Hercules Technology Growth Capital | $10M |
Medrobotics Corporation (formerly Cardioborobotics, Inc.) is a Delaware “C” Corporation, originally formed in 2005 (as Innovention Technologies, LLC) by the inventors of our technology. They are Howie Choset, PhD, a tenured Associate Professor of Robotics at Carnegie Mellon University, Dr. Marco Zenati, a cardiothoracic surgeon and Visiting Professor of Surgery at Harvard Medical School, and Dr. Alon Wolf, Associate Professor at Technion University in Israel. Dr. Zenati was on the medical faculty of the University of Pittsburgh at the time he and Drs. Choset and Wolf developed the first generation medical “snake robotics” platform in-licensed by the Company. Dr. Choset and Dr. Zenati continue to remain involved in technology development at the Company.
Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility in New England, with partners located throughout the United States.
